James Pickles will be one of our plenary speakers.

Paper title:

The Hidden cost of Yes – How and when a well placed no can be more positive than an automatic yes.

A real story of getting it wrong for the what felt like the right reasons with practical tips on how it can done differently

Session key points:

• People pleasing – successful habits aren’t always healthy
• Breaking the pattern of saying yes all the time (or feeling we have to)
• How can we say no positively in a way that is better for the client, stakeholders and ourselves?
• When say no, what might they hear?
• When no is said to us, what might we hear?

Background:

In 2019, James was a Sales Director at Toluna a global survey technology and panel company. Mine was the leading sales team in Europe dealing with major brands such as GSK, Reckitt, Unilever, P&G, Coca-Cola and many more. My team delivered double digit revenue growth, every year.

​In March of that year I suffered a completely unexpected and almost total mental and physical breakdown, following a severe and very public anxiety attack. I spent the remainder of the year on leave. 

​Throughout my career and at it’s peak, not all of my successful habits and behaviours were sustainable.

Andrée Bates from Eularis will deliver an AI workshop on 24 June 2024 (Monday)

About the training

In today’s fast-evolving landscape, Artificial Intelligence is reshaping the very core of pharmaceutical market research, while creating new avenues for innovation, efficiency, and growth. This workshop will bring you up to speed on the latest advances and approaches of the integration of AI technologies with market research, providing practical strategies and real-world applications tailored specifically for pharma market researchers from AI analysis through to synthetic responders and beyond. This training will open your eyes to how advanced the state of the art is – which may surprise you. Whether you’re a seasoned professional or new to the field, this course will empower you to harness AI’s power to drive measurable impacts within your organization.

About the trainer

Dr. Andrée Bates is a thought leader in Artificial Intelligence for Pharma and the founder and CEO of Eularis, a firm that has been focused on tackling pharma industry challenges with artificial intelligence since 2003. She has worked in this space for pharma in USA, Japan, LATAM, China, APAC, Europe, UK, EMEA, for over 20 years and has worked in pharmaceuticals for 30 years.

Dr. Bates has led AI programs for most of the top-tier pharmaceutical companies in diverse areas such as R&D, clinical trials, regulatory affairs, medical dealings, market access, market research, integrated analytics and insights, and sales and marketing. These have all resulted in measurable efficiency and growth in profit and market share for her clients.

Dr. Bates stays up-to-date on all AI relevant to pharma execs and is also a guest lecturer for numerous university MBA and Healthcare Innovation Masters programs in AI including Gabelli School of Business (Fordham University, USA), Erivan K Haub School of Business (St Joseph’s University, USA), College of Business (University of Rhode Island, USA), INSEAD Business School (France), Henley Business School (University of Reading, UK).

Dr. Bates is also an assessor for Innovate UK, UK’s national innovation agency, with her area of specialty being AI-focused start-up grants and also hosts a podcast ‘AI for Pharma Growth’ that explores AI that is relevant to pharma.